Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Acetaminophen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pain, Postoperative 2 Pain 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

cabozantinib 7 pembrolizumab 5 Nivolumab 5 Radiosurgery 3 Ipilimumab 3 Axitinib 3 lenvatinib 2 Blood Specimen Collection 2 zimberelimab 1 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 olaparib 1 gallium Ga 68 dotatate 1 brodalumab 1 belzutifan 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Ultrasonography 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Radiotherapy 1 Radionuclide Imaging 1 Radiofrequency Ablation 1 Preoperative Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡